| Literature DB >> 33578816 |
Alejandro Olivares-Hernández1,2, Luis Figuero-Pérez1,2, Juan Jesus Cruz-Hernandez2, Rogelio González Sarmiento2,3, Ricardo Usategui-Martin4,5,6, José Pablo Miramontes-González2,5,7.
Abstract
The dopaminergic system can adapt to the different physiological or pathological situations to which the kidneys are subjected throughout life, maintaining homeostasis of natriuresis, extracellular volume, and blood pressure levels. The role of renal dopamine receptor dysfunction is clearly established in the pathogenesis of essential hypertension. Its associations with other pathological states such as insulin resistance and redox balance have also been associated with dysfunction of the dopaminergic system. The different dopamine receptors (D1-D5) show a protective effect against hypertension and kidney disorders. It is essential to take into account the various interactions of the dopaminergic system with other elements, such as adrenergic receptors. The approach to therapeutic strategies for essential hypertension must go through the blocking of those elements that lead to renal vasoconstriction or the restoration of the normal functioning of dopamine receptors. D1-like receptors are fundamental in this role, and new therapeutic efforts should be directed to the restoration of their functioning in many patients. More studies will be needed to allow the development of drugs that can be targeted to renal dopamine receptors in the treatment of hypertension.Entities:
Keywords: dopamine; hypertension; kidney
Mesh:
Substances:
Year: 2021 PMID: 33578816 PMCID: PMC7916607 DOI: 10.3390/biom11020254
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X